$INNOVENT BIO (01801.HK)$solid fy24 performance. strong revenue growth powering profit turnaround. eps is reflective of actual performance with minimal help from one off revenue / accounting adjustments. solid pipeline as well.
HuatZaai
OP152505716Deb
:
It depends on one's mindset. If worried, it can be sold between 48 and 50. If it breaks above 50, there should still be room for an increase.
As of 2024, Temasek Holdings reported a net portfolio value of SGD 389 billion as of March 31. The portfolio spans sectors like technology, financial services, sustainability, consumer goods, and healthcare, reflecting their focus on trends such as digitization, sustainable living, longer lifespans, and future consumption patterns. Key Investments • Technology: Investments in AI and digital enablers, particularly in the U.S. • Healthcare: Indian hospital network Manipal...
$INNOVENT BIO (01801.HK)$It seems that this company never make a profit since its listing and the management is good at accounting and financial skills.
HuatZaai OP : Nope, not today